Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

1,756

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

February 4, 2019

Study Completion Date

February 4, 2019

Conditions
EnterovirusRhinovirus
Interventions
DRUG

Nitazoxanide

Nitazoxanide 600 mg administered orally twice daily for five days

DRUG

Placebo

Placebo administered orally twice daily for five days

Trial Locations (45)

11229

Vanguard Study Site, Brooklyn

21236

Vanguard Study Site, Baltimore

27607

Vanguard Study Site, Raleigh

30281

Vanguard Study Site, Stockbridge

32819

Vanguard Study Site, Orlando

33145

Vanguard Study Site, Miami

33155

Vanguard Study Site, Miami

33174

Vanguard Study Site, Miami

33609

Vanguard Study Site, Tampa

35124

Vanguard Study Site, Pelham

35235

Vanguard Study Site, Birmingham

35242

Vanguard Study Site, Birmingham

38305

Vanguard Study Site, Jackson

38328

Vanguard Study Site, Milan

40207

Vanguard Study Site, Louisville

43214

Vanguard Study Site, Columbus

44122

Vanguard Study Site, Cleveland

45215

Vanguard Study Site, Cincinnati

45424

Vanguard Study Site, Dayton

46383

Vanguard Study Site, Valparaiso

59808

Vanguard Study Site, Missoula

60201

Vanguard Study Site, Evanston

63141

Vanguard Study Site, St Louis

68005

Vanguard Study Site, Bellevue

70115

Vanguard Study Site, New Orleans

70124

Vanguard Study Site, New Orleans

71913

Vanguard Study Site, Hot Springs

75010

Vanguard Study Site, Carrollton

75024

Vanguard Study Site, Plano

77058

Vanguard Study Site, Houston

78504

Vanguard Study Site, McAllen

78735

Vanguard Study Site, Austin

83221

Vanguard Study Site, Blackfoot

83642

Vanguard Study Site, Meridian

83686

Vanguard Study Site, Nampa

84010

Vanguard Study Site, Bountiful

84790

Vanguard Study Site, St. George

89104

Vanguard Study Site, Las Vegas

90744

Vanguard Study Site, Wilmington

92683

Vanguard Study Site, Westminster

92805

Vanguard Study Site, Anaheim

97504

Vanguard Study Site, Medford

02914

Vanguard Study Site, East Providence

00780

Vanguard Study Site, Ponce

00926

Vanguard Study Site, San Juan

All Listed Sponsors
lead

Romark Laboratories L.C.

INDUSTRY

NCT03605862 - Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection | Biotech Hunter | Biotech Hunter